Cytokinetics Inc vs Sasol Ltd. American Depositary Shares — how do they compare? Cytokinetics Inc trades at $61.95 (market cap $8.62B), while Sasol Ltd. American Depositary Shares trades at $15.05 (market cap $9.25B). The key difference: Cytokinetics Inc and Sasol Ltd. American Depositary Shares are close in size by market cap, and Sasol Ltd. American Depositary Shares is trading nearer its 52-week high, Cytokinetics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cytokinetics Inc for 19 Days and Sasol Ltd. American Depositary Shares for 0 Days on average.
| CYTK | SSL | |
|---|---|---|
Market Cap | $8.62B | $9.25B |
Volume | 2,594,626 | 1,222,173 |
Sector | Health | Basic Materials |
52-Week High | $87.26 | $15.14 |
52-Week Low | $54.76 | $5.33 |
Typical Hold Time | 19 Days | 0 Days |
Enterprise Value | $8.72B | $12.97B |
Signals from Pluang's Aura AI — not financial advice
CYTK trades at $61.12, down 0.37% on the day, with a bearish technical signal from moving averages but bullish momentum from oscillators. The company reported a net loss of -$784.96M on $88.04M revenue in 2025, with a negative net income margin of -1,321.12%. Recent news highlights clinical progress for aficamten in hypertrophic cardiomyopathy, including Phase 3 results and real-world study launches.
Despite heavy losses, strong analyst consensus (97.14% buy ratings) and a $112.50 price target reflect optimism for its heart failure pipeline. Key risks include sustained cash burn, competitive pressure from Bristol Myers Squibb's Camzyos, and the need for successful commercialization to justify its high P/S ratio of 112.42.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →Sasol Limited is a Johannesburg-headquartered chemicals and energy company that uses its proprietary Fischer-Tropsch technology to convert coal, natural gas, and crude-oil feedstocks into fuels and chemical products such as polymers, solvents, surfactants, and ammonia, with operations across Southern Africa and international chemical manufacturing sites, including in US.
Read more on SSL →